BioMarin’s dwarfism drug Voxzogo could be its next blockbuster, but ethics questions loom over the launch esagonowsky Fri, […]
Japan sees ‘drug lag’ as foreign pharmas pass up the market amid pricing pressure, industry group warns aliu […]
Biden’s Medicare drug price negotiations will leave pharma mostly unscathed: CBO fkansteiner Fri, 11/19/2021 – 09:52
Fierce Pharma Asia—Biocon, Viatris’ insulin biosim launch; AstraZeneca China’s deceleration; Huahai’s FDA warning lift aliu Fri, 11/19/2021 – […]
Chemistry researchers have developed a new method using blue light to create pharmaceuticals in a more sustainable way, […]
No surprises for PfizerThe phase II/III double-blind randomised controlled trial of Pfizer’s BNT162b2 vaccine in 5-11 year olds […]
The Global Health infrastructure is broken. We are attempting to put plasters on multiple compound fractures—a useless and […]
A nationwide network of family hubs should be put at the core of a national strategy on child […]
Clinicians are driven by a common mission: to optimally improve health, prevent harm, and advance equity. This means […]
More than 650 health experts and activists are calling on the government to back amendments in the forthcoming […]